Definitive Stereotactic Body Radiotherapy (SBRT) for Extracranial Oligometastases

Overview of attention for article published in American Journal of Clinical Oncology: Cancer Clinical Trials, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 23,474 followers.

RT @DrewMoghanaki: Here's a survey of >1,000 radiation oncologists to learn why some are, or aren't, using SBRT for oligomets. #radonc http…

RT @DrewMoghanaki: Here's a survey of >1,000 radiation oncologists to learn why some are, or aren't, using SBRT for oligomets. #radonc http…

RT @DrewMoghanaki: Here's a survey of >1,000 radiation oncologists to learn why some are, or aren't, using SBRT for oligomets. #radonc http…

RT @DrewMoghanaki: Here's a survey of >1,000 radiation oncologists to learn why some are, or aren't, using SBRT for oligomets. #radonc http…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.